Investing to improve
the human condition

About Us

from seed to market.

The Trendlines Group invests in innovations in agrifood technologies and medtech, leveraging our experience, network, and resources to go from seed to market.


Vensica has developed minimally invasive solutions in urology, unlocking the unique properties of therapeutic ultrasound to deliver neurotoxins.

Working with Trendlines

Vensica’s journey from our establishment in 2014, through to our strategic partnership with Merz and the latest investment round, took many twists and turns. Trendlines was there for us at each stage.

Avner Geva, CEO Vensica Therapeutics


Strategic license and collaboration agreement with Merz Therapeutics

Full development of a needle-less delivery system utilizing the power of therapeutic ultrasound

$19 million investment round led by Israeli VC IBF


Phytolon revolutionizes the way food colors are produced, bringing natural colors to the next level in terms of ...

Working with Trendlines

The investments of DSM Venturing, Cibus Fund, and Ginkgo Bioworks open the door for broad penetration of our products in the global food industry.  We are excited to have new investors who share our vision to create healthy, efficient, and sustainable food systems via biotechnology.

Halim Jubran PhD, Co-founder and CEO of Phytolon


Closed $14.5 million Series A funding round

Signed collaboration with Ginkgo Bioworks

Selected as one of top 30 global start-ups at SLINGSHOT 2019, Singapore, November 2019



Bridging the financing gap for smallholder producers
AI-driven analytics platform for early detection and monitoring of crop diseases
Changing the way we consume vegetables
Novel treatment option for adolescent idiopathic scoliosis (AIS)
Sustainable increase of fish yields with same resources
All-suture, knotless, meniscus repair system
EcoPhage is developing sustainable and effective, phage-based solutions for crop protection
Non-surgical, incision-free approach to treat pelvic organ prolapse
Bringing accuracy to fruit yield estimation
Robotic system for greenhouses
Healthy, efficient, and sustainable natural food color alternatives
Cryotherapy for treatment of superficial bladder cancer
Orally administered health management delivery platform for aquaculture
Spinal fusion re-imagined

How we do it

Our global team brings together science, technology, and business expertise to invest in and build innovation-based healthcare and agrifood companies.

how we invest

how we partner

how we connect with you


14 February 2024

Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment

Investors include an undisclosed global strategic investor, ALIVE VC and Agriline

21 January 2024

Trendlines listed as one of OTCQX Best 50

6 December 2023

Nufarm and IBI Ag collaborating to bring to market novel bioinsecticides



    Misgav, Israel

    Misgav Business Park, 17 T’chelet Street M.P. Misgav, 2017400

    Tel: +972.72.260.7000

    location icon


    Blk 77, Ayer Rajah Crescent, #02-21/26 Singapore, 139954

    Tel: +65.6461.7000

    location icon
    Skip to content